Marengo Therapeutics
Clinical-stage biotechnology company developing novel T cell-engaging immunotherapies for cancer, including the lead candidate Invikafusp alfa (STAR0602) for PD-1-resistant solid tumors.
Website
https://www.marengotx.comLocation
Cambridge, Massachusetts, USA
Founded
2018
Investors
1
Categories
biotech, immunotherapy, oncology, cancer, biologics
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Apple Tree Partners | New York, USA | biotech-focused | series-aseries-b+2 | 23 |
